A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Name: A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
License: Public Domain

FBD Biologics Limited

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced solid tumor, refractory non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148742
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.